Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma - Test2 - elhamkhani - TriplyDB

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

http://www.wikidata.org/entity/Q24241711

about

Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells.Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma.Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study.Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma.Current status of multimodal & combination therapy for hepatocellular carcinoma.Glutamine synthetase predicts adjuvant TACE response in hepatocellular carcinoma A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers Developments in cancer vaccines for hepatocellular carcinoma.Treatment of Liver Cancer.Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors.Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma.Factors associated with early cancer-related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion.Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.Contemporary strategies in the management of hepatocellular carcinoma Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma Current immunotherapeutic strategies in hepatocellular carcinoma: recent advances and future directions.Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence.Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy.Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.Das hepatozelluläre Karzinom

P2860

Q33948280-8B6C10B8-A6AA-4053-90DE-0250E41CF5C0 Q33990018-75057BB8-D736-49FB-918B-845A620F26A0 Q34017748-F73168F1-AE84-4020-8682-4F74F8D6AEEC Q34612069-F0B53456-FDCA-4972-B6EC-1DB26092D97C Q34669200-87B57E0F-9ADC-4399-9079-63D81ABA6991 Q35055436-E9F979AA-E6BF-4C7B-BFAC-F0F8555864EC Q35698198-D1FDC735-6231-48B5-8317-897899359995 Q35771842-E98FCB1B-CBF0-4905-900E-254D296223B3 Q35843875-8AB489A6-4083-48A6-9985-1DFA6C217335 Q35870450-A867B0DD-B725-4303-88A2-DBE3B85CFC66 Q36010821-CF162FE9-F2C0-45A1-B7BE-4A397BAE3336 Q36322143-CD30A89C-58BA-4E28-9865-BAAC5BF79DD5 Q36429818-47F2C41D-82E6-4923-BA62-F8C3BA8FBF2E Q36432130-B838C632-0C8F-49F0-ABAF-9D463BE6C9B0 Q36436294-1F2336DA-BE4C-4D0C-8F97-DE6892282BA3 Q36492831-8014AF58-B7B6-4F2D-B165-2C0980722515 Q36934253-950E6398-961B-4C79-AE8F-D99D26956FE8 Q37420812-B1E39034-D95F-40D8-A4B5-61357E24559D Q37631655-7834CAF7-C8E0-461B-8A2D-AACAC6AFE475 Q38533017-3E01D7A5-EFFF-4149-8686-63986AADCCB4 Q38549768-42D3AA93-BF3F-4484-B1F0-6858FCD4708C Q38620322-A306B0CD-3A5C-4C1E-8AEE-1C49A51F05B8 Q38825761-5DAE5C30-C266-40E5-9176-AD4140CB27D8 Q39396995-A3168F15-4D67-473D-B236-A56DD81B0932 Q41127791-FA199272-BF2B-47AA-8733-C663C57F494D Q41659507-EB8891BE-6BA1-4D49-B0EE-B950362FBBBA Q41808165-C752182F-16AF-4A51-BF60-2DBE87E5045B Q42279064-EC9A35B1-5734-4390-8F06-CC5AC514D8EE Q42375643-0A156506-5BA6-41D4-AD10-6453082D711F Q43000512-25B9DAB7-DEC7-405D-BAE3-B81ABF1D38B1 Q55268430-F4573E70-71AF-4E97-87C6-7FDDFF2CDA44 Q55505579-12FF9EB8-990D-46B9-9777-CACE1C6485DD Q58011404-4715C4A0-7F00-404E-9125-DE2E6DEC7487

P2860

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

http://www.wikidata.org/entity/Q24241711

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@ast

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en-gb

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@nl

type

label

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@ast

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en-gb

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@nl

prefLabel

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@ast

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en-gb

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@nl

P1433

Q24241711-A33C9B88-0A22-41CD-BA28-CCF94522396E

P1476

Q24241711-E6186467-CF6C-4417-9854-1E17A7B5E008

P2093

Q24241711-59473B7E-CB1A-408E-80C1-E0523821E078

Q24241711-5E145AD7-2BB1-4C28-8D53-D20CBD5C8090

Q24241711-6A4B73F9-D673-4404-AD70-76FDB9AC2DA8

Q24241711-7831AD75-F6EF-410F-9885-5DBE7498949F

P2860

Q24241711-3E960AE9-BC0F-4155-AD77-0558C53E68D8

Q24241711-7DE183DE-814C-44CA-9AF6-2A1E564F5FCF

Q24241711-BD074E63-3468-47E3-9F77-DF1EB20DCCF5

P304

Q24241711-AAA47844-1EA3-4B50-AD38-41C4125C0027

P31

Q24241711-4890ddf6-8f54-476f-ba9c-aca1a760dd6b

Q24241711-EE83F8E3-9788-4979-B332-E1FD07B87EF8

P356

Q24241711-60A39508-0AC7-41B1-9A3D-06199249AFEA

P433

Q24241711-EF3AF750-765B-4D0B-8BD8-B70860A79BAE

P50

Q24241711-23974F0C-17E1-4890-BD7E-570D2DD20091

P577

Q24241711-43C64DB7-7572-42D1-AAAD-891DA5F5E768

P698

Q24241711-7A9D1761-7D1E-414C-AE1F-A7D9DBC52FBF

P356

14651858.CD001199.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

@en

P2093

David Machin

http://www.w3.org/2001/XMLSchema#string

Edwin Chan Shih-Yen

http://www.w3.org/2001/XMLSchema#string

Khee-Chee Soo

http://www.w3.org/2001/XMLSchema#string

Miny Samuel

http://www.w3.org/2001/XMLSchema#string

P2860

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

P304

CD001199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD001199.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19160192

http://www.w3.org/2001/XMLSchema#string